Back to News & Media

Select Media Coverage

April 11, 2024

Fierce Biotech: AACR: Verastem, Quanta and Frontier demonstrate KRAS inhibitors' potential in preclinical data

February 22, 2024

Fierce Biotech: Frontier CEO weathers 'one of the hardest financings' of his career to close $80M series C

February 22, 2024

San Francisco Business Times: Peninsula biotech raises $80M as it doses 1st person in 1st clinical trial